###begin article-title 0
###xml 78 83 <span type="species:ncbi:10090">Mouse</span>
DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
###end article-title 0
###begin p 1
Conceived and designed the experiments: CN CP FG NJ JMD. Performed the experiments: CN CP CR FG AD NB. Analyzed the data: CN CP FG VD JLP AB NJ JMD. Contributed reagents/materials/analysis tools: AD BdF YG HB YH. Wrote the paper: NJ JMD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
Hyperhomocysteinemia, characterized by increased plasma homocysteine level, is associated with an increased risk of atherosclerosis. On the contrary, patients with Down syndrome appear to be protected from the development of atherosclerosis. We previously found a deleterious effect of hyperhomocysteinemia on expression of DYRK1A, a Down-syndrome-associated kinase. As increased expression of DYRK1A and low plasma homocysteine level have been associated with Down syndrome, we aimed to analyze the effect of its over-expression on homocysteine metabolism in mice.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 695 703 <span type="species:ncbi:9606">patients</span>
Effects of DYRK1A over-expression were examined by biochemical analysis of methionine metabolites, real-time quantitative reverse-transcription polymerase chain reaction, and enzyme activities. We found that over-expression of Dyrk1a increased the hepatic NAD(P)H:quinone oxidoreductase and S-adenosylhomocysteine hydrolase activities, concomitant with decreased level of plasma homocysteine in three mice models overexpressing Dyrk1a. Moreover, these effects were abolished by treatment with harmine, the most potent and specific inhibitor of Dyrk1a. The increased NAD(P)H:quinone oxidoreductase and S-adenosylhomocysteine hydrolase activities were also found in lymphoblastoid cell lines from patients with Down syndrome.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our results might give clues to understand the protective effect of Down syndrome against vascular defect through a decrease of homocysteine level by DYRK1A over-expression. They reveal a link between the Dyrk1a signaling pathway and the homocysteine cycle.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 458 460 458 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 644 647 644 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Selhub1">[1]</xref>
###xml 874 875 874 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1225 1228 1225 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Selhub1">[1]</xref>
Homocysteine (Hcy) is a sulfur-containing amino acid formed during the intracellular conversion of methionine via the adenosylated compounds S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH). The formation of SAM is catabolized by methionine adenosyl transferase (MAT). Once Hcy is formed, it may be recycled to methionine after remethylation by two different pathways. The first one involves methionine synthase (MS), an enzyme that uses vitamin B12 (cobalamin) as an essential cofactor and 5-methyltetrahydrofolate as the methyl donor. The 5-methyltetrahydrofolate is generated by 5, 10-methylene tetrahydrofolate reductase (MTHFR) [1]. The second pathway, which occurs in liver and kidney, involves the enzyme betaine-homocysteine methyltransferase (BHMT). Hcy may also undergo condensation with serine to form cystathionine, which is catalyzed by the vitamin B6-dependent enzyme cystathionine beta synthase (CBS), the first enzyme involved in the transsulfuration pathway. Cystathionine is subsequently hydrolysed to form cysteine which can be, in turn, incorporated into protein or used to synthesize the antioxidant glutathione. Hcy can also turn back to SAH via reversal of the SAH hydrolase (SAHH) reaction [1].
###end p 9
###begin p 10
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Welch1">[2]</xref>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Murdoch1">[3]</xref>
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Draheim1">[4]</xref>
###xml 522 525 522 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-YlaHerttuala1">[5]</xref>
###xml 688 691 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Licastro1">[6]</xref>
###xml 1132 1135 1132 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Becker1">[7]</xref>
###xml 1136 1139 1136 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Laguna1">[9]</xref>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hamelet1">[10]</xref>
###xml 1469 1472 1469 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Licastro1">[6]</xref>
###xml 1474 1478 1474 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Pogribna1">[11]</xref>
###xml 1479 1483 1479 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Galletti1">[13]</xref>
###xml 1715 1719 1715 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Watanabe1">[14]</xref>
###xml 1810 1814 1810 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Smith1">[15]</xref>
###xml 2201 2205 2201 2205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Davisson1">[16]</xref>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
###xml 473 481 <span type="species:ncbi:9606">patients</span>
###xml 552 560 <span type="species:ncbi:9606">patients</span>
###xml 872 877 <span type="species:ncbi:9606">human</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
###xml 1249 1255 <span type="species:ncbi:10090">murine</span>
###xml 1854 1860 <span type="species:ncbi:10090">murine</span>
###xml 1897 1902 <span type="species:ncbi:9606">human</span>
###xml 1985 1990 <span type="species:ncbi:10090">mouse</span>
###xml 2166 2171 <span type="species:ncbi:10090">mouse</span>
###xml 2181 2186 <span type="species:ncbi:9606">human</span>
Elevated plasma Hcy levels are well-recognized as an independant risk factor for atherosclerosis in the coronary, cerebrovascular and peripheral arterial circulation [2]. Conversely, although Down syndrome (DS) is associated with a great variety of phenotypes, the incidence of atherosclerotic vascular disease seems to be low [3], [4]. Even if the coronary arteries of DS patients were not completely free of atherosclerosis, it was milder than in other mentally retarded patients and in control subjects of the same age [5]. Moreover, healthy old DS patients showed some classical biochemical risk factors for atherosclerosis but did not suffer from clinical cardiovascular alterations [6]. Because many genetic factors can be related to this reduction, the reasons for this apparent protection against atherosclerosis remain unclear. DYRK1A, which gene is localized on human chromosome 21, is a protein kinase that belongs to an evolutionarily conserved family of proteins known as DYRKs (dual-specificity tyrosine-(Y)-phosphorylation regulated kinase) involved in diverse functions ranging from development, growth to apoptosis [7]-[9]. On the one hand, we recently reported a reduction of Dyrk1a protein level in liver of CBS-deficient mice, a murine model of hyperhomocysteinemia [10], suggesting a link between DYRK1A related pathways and the Hcy cycle. On the other hand, an increased expression of DYRK1A and low plasma Hcy levels have been associated with DS [6], [11]-[13]. To analyze further the relation between DYRK1A and Hcy metabolism, we used four transgenic models to demonstrate the effect of the over-expression of Dyrk1a on Hcy metabolism: a model of hyperhomocysteinemia due to CBS deficiency [14] and three models with duplications of increasing complexity and over-expression of Dyrk1a [15]: a BAC transgenic with one copy of the murine Dyrk1a gene; a YAC transgenic for a human chromosome 21 fragment carrying five genes including DYRK1A; a partial trisomy 16 mouse carrying an extra copy of a region of MMU16 syntenic for a region of HSA21 between Mrpl39 and Znf295 containing 138 genes (also including Dyrk1a) and considered to be a valid mouse model of human Down syndrome [16].
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 56 60 <span type="species:ncbi:10090">mice</span>
DYRK1A over-expression reduces the plasma Hcy levels in mice
###end title 12
###begin p 13
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Davisson2">[17]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Holtzman1">[18]</xref>
###xml 688 695 688 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g001">Fig. 1A</xref>
###xml 788 794 788 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dyrk1a</italic>
###xml 828 835 828 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g001">Fig. 1B</xref>
###xml 924 930 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dyrk1a</italic>
###xml 964 971 964 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g001">Fig. 1D</xref>
###xml 1147 1153 1147 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g002">Fig. 2</xref>
###xml 1158 1170 1158 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g001">Figs. 1C, 1E</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 133 139 <span type="species:ncbi:10090">murine</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 271 277 <span type="species:ncbi:10090">murine</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 671 686 <span type="species:ncbi:10090">transgenic mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 811 826 <span type="species:ncbi:10090">transgenic mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 947 962 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
In order to analyze the over-expression of DYRK1A on plasma Hcy levels, we used three models of mice, which overexpress not only the murine gene, but also the human one. The transgenic line (Tg) 152F7 contains five human genes including DYRK1A. The Tg 189N3 contains the murine orthologue of DYRK1A. The Ts65Dn line is the most complete of the commonly available mouse models of the mouse partial trisomy 16 and exhibits morphological and biochemical changes seen in DS [17], [18]. We first analyzed the overexpression of DYRK1A in liver of mice. Male Tg 152F7 mice, two months of age, showed a two-fold increase in gene expression of DYRK1A in the liver compared to non-transgenic mice (Fig. 1A). Female Tg 189N3 mice, two months of age, showed a 1.4-fold increase in gene expression of Dyrk1a compared to non-transgenic mice (Fig. 1B). Male Ts65Dn mice, six months of age, showed a 1.6-fold increase in gene expression of Dyrk1a compared to non-transgenic mice (Fig. 1D). Commensurate with the mRNA expression, protein expression of DYRK1A was 1.3 fold, 1.6 fold and 1.7 fold higher in liver of Tg 152F7, Tg 189N3, and Ts65Dn mice respectively (Fig. 2 and Figs. 1C, 1E).
###end p 13
###begin title 14
###xml 55 70 <span type="species:ncbi:10090">transgenic mice</span>
Hepatic DYRK1A mRNA and protein expression in liver of transgenic mice.
###end title 14
###begin p 15
###xml 447 448 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
Relative expression of DYRK1A gene was based on Q-PCR data and protein expression was determined by normalization of the density of images from DYRK1A with that of beta-actin of the same blot. The values of Tg 152F7, Tg189N3 and Ts65Dn were normalized to the mean Tg - mice from each lines. The blots are representative of three independent experiments. Data correspond to means +/- SEM and the statistical analysis was done by Student's unpaired t-tests. n = number of mice.
###end p 15
###begin title 16
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
DYRK1A protein expression in liver of CBS-deficient mice crossbred with 152F7 transgenic mice.
###end title 16
###begin p 17
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 599 602 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 602 605 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 612 615 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 615 618 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 632 635 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 635 638 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 679 682 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 682 685 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 881 882 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 131 146 <span type="species:ncbi:10090">transgenic mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 209 224 <span type="species:ncbi:10090">transgenic mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
(A) Western immunoblots showing DYRK1A expression in liver of wild type mice (Cbs+/+ Tg -), heterozygous mice (Cbs+/- Tg -), 152F7 transgenic mice (Cbs+/+ Tg 152F7), and heterozygous mice crossbred with 152F7 transgenic mice (Cbs+/- Tg 152F7). Proteins were subjected to immunoblot analysis using antibodies specific to DYRK1A (85.5 kDa). After stripping, the membranes were reprobed with anti-beta-actin antibody (41.7 kDa) for the control. (B) Relative protein expression was determined by normalization of the density of images from DYRK1A with that of beta-actin of the same blot. The values of Cbs+/- Tg -, Cbs+/+ Tg 152F7, or Cbs+/- Tg 152F7 were normalized to the mean of Cbs+/+ Tg - mice. The blots are representative of three independent experiments. Data correspond to means +/- SEM and the statistical analysis was done with one-way ANOVA followed by Student's unpaired t-tests. n = number of mice.
###end p 17
###begin p 18
###xml 128 131 128 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 207 210 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3A</xref>
###xml 236 243 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t001">Table 1</xref>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3A</xref>
###xml 329 336 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t001">Table 1</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hamelet1">[10]</xref>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 443 449 443 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g002">Fig. 2</xref>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 492 495 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 502 505 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 515 521 515 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g002">Fig. 2</xref>
###xml 524 527 524 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 566 569 566 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 569 572 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 583 589 583 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g002">Fig. 2</xref>
###xml 665 668 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 668 671 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 678 681 678 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 681 684 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 691 697 691 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g002">Fig. 2</xref>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 729 732 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 739 742 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 742 745 742 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 752 759 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3A</xref>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 798 801 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 811 814 811 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 821 828 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3A</xref>
###xml 840 843 840 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 843 846 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 885 888 885 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 899 906 899 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3A</xref>
###xml 954 957 954 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 957 960 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 967 970 967 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 970 973 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 980 987 980 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3A</xref>
###xml 1114 1121 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t001">Table 1</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1084 1099 <span type="species:ncbi:10090">transgenic mice</span>
In order to show the effect of over-expression of DYRK1A on plasma Hcy level, serum of Tg 152F7 and heterozygous CBS-deficient (Cbs+/-) mice crossbred with Tg 152F7 mice was analyzed by HPLC. Tg 152F7 mice (Cbs+/+ Tg 152F7; Fig. 3A and Table 1) have a Hcy level 1.4-fold lower than those of Cbs+/+ mice (Cbs+/+ Tg -; Fig. 3A and Table 1). As previously shown [10], Dyrk1a protein expression was decreased in liver of Cbs+/- mice (Cbs+/- Tg -; Fig. 2), compared with protein extracted from Cbs+/+ mice (Cbs+/+ Tg -; Fig. 2). Cbs+/- mice crossbred with Tg 152F7 mice (Cbs+/- Tg 152F7; Fig. 2) also showed a 1.3 fold-increased hepatic expression of DYRK1A compared to Cbs+/- mice (Cbs+/- Tg -; Fig. 2). As expected, Hcy level of Cbs+/- mice (Cbs+/- Tg -; Fig. 3A) was 1.7-fold higher than those of Cbs+/+ mice (Cbs+/+ Tg -; Fig. 3A). However, Cbs+/- mice crossbred with Tg 152F7 mice (Cbs+/- Tg 152F7; Fig. 3A) have a Hcy level 1.4-fold lower than those of Cbs+/- mice (Cbs+/- Tg -; Fig. 3A). Tg 189N3 and Ts65Dn mice have also a Hcy level 2.35-fold and 1.4-fold lower than those of non-transgenic mice respectively (Table 1). These results emphasize the effect of over-expression of DYRK1A on plasma Hcy level, not only in case of hyperhomocysteinemia but also in the context of DS.
###end p 18
###begin title 19
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 102 117 <span type="species:ncbi:10090">transgenic mice</span>
Plasma Hcy level is decreased in 152F7 transgenic mice and in CBS-deficient mice crossbred with 152F7 transgenic mice.
###end title 19
###begin p 20
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 300 303 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 436 437 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 142 157 <span type="species:ncbi:10090">transgenic mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 220 235 <span type="species:ncbi:10090">transgenic mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
(A) Plasma Hcy level, (B) hepatic CBS, (C) SAHH and (D) NQO1 activity in wild type mice (Cbs+/+ Tg -), heterozygous mice (Cbs+/- Tg -), 152F7 transgenic mice (Cbs+/+ Tg 152F7), and heterozygous mice crossbred with 152F7 transgenic mice (Cbs+/- Tg 152F7). The values were normalized to the mean of Cbs+/+ Tg - mice. Data correspond to means +/- SEM and the statistical analysis was done with one-way ANOVA followed by Student's unpaired t-tests. n = number of mice.
###end p 20
###begin title 21
###xml 84 99 <span type="species:ncbi:10090">transgenic mice</span>
Plasma Hcy levels, hepatic SAM and SAH concentrations, and hepatic SAM/SAH ratio in transgenic mice.
###end title 21
###begin p 22
###xml 93 94 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 104 105 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 112 118 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 112 118 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8224;</sup></bold>
###xml 118 119 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 126 139 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 126 139 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8225;</sup></bold>
###xml 139 140 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data correspond to means +/- SEM and the statistical analysis was done by Student's unpaired t-tests. * p<0.04; daggerp<0.01; double daggerp<0.002.
###end p 22
###begin title 23
DYRK1A over-expression modulates SAHH activity
###end title 23
###begin p 24
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Finkelstein1">[19]</xref>
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Stead1">[20]</xref>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3B</xref>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 252 259 252 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3B</xref>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3B</xref>
###xml 343 346 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 346 349 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3B</xref>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3B</xref>
###xml 495 498 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 529 532 529 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 557 563 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 573 574 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 593 594 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 600 601 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 636 642 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 652 653 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 672 673 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 679 680 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 749 764 <span type="species:ncbi:10090">transgenic mice</span>
As CBS is a key enzyme of Hcy metabolism [19], [20], we first assayed the CBS activity in liver samples of mice. As expected, Cbs+/- mice (Cbs+/- Tg -; Fig. 3B) showed a significant decrease of CBS activity when compared with Cbs+/+ mice (Cbs+/+ Tg -; Fig. 3B). Tg 152F7 mice (Cbs+/+ Tg 152F7; Fig. 3B) have the same CBS activity than that of Cbs+/+ mice (Cbs+/+ Tg -; Fig. 3B). However, Cbs+/- mice crossbred with Tg 152F7 mice (Cbs+/- Tg 152F7; Fig. 3B) showed a decrease of CBS activity like Cbs+/- mice when compared with Cbs+/+ mice. Tg 189N3 (110+/-4 versus 100+/-7; p<0.26 by Student's t test n = 5 for each) and Ts65Dn (111+/-7 versus 100+/-3; p<0.17 by Student's t test n = 5 for each) mice have also the same CBS activity than that of non-transgenic mice. Then our results show that dyrk1a overexpression has no effect on CBS activity.
###end p 24
###begin p 25
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 143 150 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3C</xref>
###xml 207 210 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 233 240 233 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3C</xref>
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 256 259 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3C</xref>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 394 397 394 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 407 414 407 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3C</xref>
###xml 427 434 427 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g004">Fig. 4A</xref>
###xml 448 455 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g004">Fig. 4B</xref>
###xml 736 743 736 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t001">Table 1</xref>
###xml 885 892 885 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t001">Table 1</xref>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 522 537 <span type="species:ncbi:10090">transgenic mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 719 734 <span type="species:ncbi:10090">transgenic mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 829 844 <span type="species:ncbi:10090">transgenic mice</span>
As Hcy can revert back to SAH via the SAHH mediated reverse reaction, we assayed SAHH activity in mouse liver. Tg 152F7 mice (Cbs+/+ Tg 152F7; Fig. 3C) showed an increase of SAHH activity when compared with Cbs+/+ mice (Cbs+/+ Tg -; Fig. 3C). Moreover, Cbs+/- mice crossbred with Tg 152F7 mice (Cbs+/- Tg 152F7; Fig. 3C) counteracted the decreased SAHH activity when compared with Cbs+/- mice (Cbs+/- Tg -; Fig. 3C). Tg 189N3 (Fig. 4A) and Ts65Dn (Fig. 4B) mice also showed an increased SAHH activity when compared to non-transgenic mice. We also determined the hepatic levels of SAM and SAH in Tg mice overexpressing DYRK1A and found that levels of SAM and SAH in liver of Tg 152F7 and Tg189N3 did not differ from non-transgenic mice (Table 1). However, we found a decreased level of SAM in liver of Ts65Dn mice compared to non-transgenic mice, leading to decreased SAM to SAH ratio (Table 1).
###end p 25
###begin title 26
###xml 58 73 <span type="species:ncbi:10090">transgenic mice</span>
Hepatic SAHH activity is increased in Tg 189N3 and Ts65Dn transgenic mice.
###end title 26
###begin p 27
###xml 223 224 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 45 60 <span type="species:ncbi:10090">transgenic mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
SAHH activity in (A) Tg 189N3 and (B) Ts65Dn transgenic mice. The values were normalized to the mean of Tg - mice from each line. Data correspond to means +/- SEM and the statistical analysis was done by Student's unpaired t-test. n = number of mice.
###end p 27
###begin p 28
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mat1a</italic>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bhmt</italic>
###xml 310 312 310 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ms</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mthfr</italic>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t002">Table 2</xref>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sahh</italic>
###xml 495 502 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t002">Table 2</xref>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 370 385 <span type="species:ncbi:10090">transgenic mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 478 493 <span type="species:ncbi:10090">transgenic mice</span>
In order to determine if other enzymes of the methionine and folate cycles are altered, we assayed the mRNA expression of the major enzymes involved in the metabolism of Hcy in the liver of Tg 189N3. We found that even if the Mat1a mRNA expression was not affected in Tg 189N3 mice (data not shown), the Bhmt, Ms and Mthfr mRNA expression were increased compared to non-transgenic mice (Table 2). However, the Sahh mRNA expression was decreased in Tg 189N3 mice compared to non-transgenic mice (Table 2).
###end p 28
###begin title 29
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Relative expression of SAHH, BHMT, MS and MTHFR gene based upon Q-PCR data obtained from non-transgenic and Tg189N3 mice.
###end title 29
###begin p 30
###xml 154 155 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 184 185 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 195 201 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 195 201 193 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8224;</sup></bold>
###xml 201 202 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
The values of Tg189N3 were normalized to the mean Tg - mice. Data correspond to means +/- SEM and the statistical analysis was done by Student's unpaired t-tests. n = number of mice. *p = 0.068; daggerp< 0.03.
###end p 30
###begin title 31
Plasma Hcy level is negatively correlated with hepatic DYRK1A expression and SAHH activity
###end title 31
###begin p 32
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hamelet1">[10]</xref>
###xml 455 462 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g005">Fig. 5A</xref>
###xml 518 525 514 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g005">Fig. 5B</xref>
###xml 651 658 645 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g005">Fig. 5C</xref>
###xml 797 804 791 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g005">Fig. 5D</xref>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
We previously observed a negative correlation between plasma Hcy levels and hepatic DYRK1A expression, which emphasizes the effect of hyperhomocysteinemia on DYRK1A expression [10]. Then we investigated if there are any links between Hcy concentration, hepatic DYRK1A protein expression and hepatic SAHH activity. We observed a significant negative correlation between plasma Hcy level and not only hepatic DYRK1A protein expression (rho = -0.48, p<0.04; Fig. 5A) but also hepatic SAHH activity (rho = -0.61, p<0.006; Fig. 5B). Moreover, hepatic DYRK1A protein expression was also positively correlated with hepatic SAHH activity (rho = 0.47, p<0.05; Fig. 5C). Multivariate analysis revealed a negative correlation between plasma Hcy level and hepatic DYRK1A protein expression and SAHH activity (Fig. 5D), indicating that high Hcy levels are associated with low hepatic DYRK1A protein expression and low hepatic SAHH activity in mice.
###end p 32
###begin title 33
Plasma Hcy level, DYRK1A protein expression and SAHH activity are correlated.
###end title 33
###begin p 34
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 560 561 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Hepatic DYRK1A expression and SAHH activity are presented as percent of Cbs+/+ Tg - mice. Correlation of plasma Hcy level vs. (A) hepatic DYRK1A protein expression or (B) hepatic SAHH activity. Increasing levels of plasma Hcy and hepatic DYRK1A protein expression or SAHH activity are negatively correlated at p<0.04 and p<0.006 with a rho = -0.48 and rho = -0.61 respectively. Correlation of hepatic DYRK1A protein expression vs. SAHH activity (C). Increasing levels of hepatic DYRK1A protein expression and hepatic SAHH activity are positively correlated at p<0.05 with a rho = 0.47. (D) Graph of PCA. The three quantitative variables corresponding of plasma Hcy level, hepatic DYRK1A protein expression and hepatic SAHH activity are represented by vectors.
###end p 34
###begin title 35
DYRK1A over-expression modulates NQO1 activity
###end title 35
###begin p 36
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sahh</italic>
###xml 80 87 80 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t002">Table 2</xref>
###xml 120 126 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 140 141 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 161 162 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 168 169 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 388 392 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hershfield1">[21]</xref>
###xml 591 594 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 594 597 590 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 608 615 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3D</xref>
###xml 684 691 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3D</xref>
###xml 696 703 692 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t003">Table 3</xref>
###xml 716 719 712 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 719 722 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 758 761 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 761 764 757 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 775 782 771 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3D</xref>
###xml 844 847 840 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 847 850 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 857 860 853 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 860 863 856 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 870 877 866 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g003">Fig. 3D</xref>
###xml 1036 1043 1032 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t003">Table 3</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 206 221 <span type="species:ncbi:10090">transgenic mice</span>
###xml 514 529 <span type="species:ncbi:10090">transgenic mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 667 682 <span type="species:ncbi:10090">transgenic mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
###xml 1019 1034 <span type="species:ncbi:10090">transgenic mice</span>
We found that the Sahh mRNA expression not only was decreased in Tg 189N3 mice (Table 2) but also in Ts65Dn (69.6+/-5.6 versus 102.1+/-8.5; p<0.005 by Student's t test n = 4 for each mouse) compared to non-transgenic mice. The increased activity of NAD(P)H:quinone oxidoreductase (NQO1) is followed by an increase of a by-product of the enzyme reaction, NAD+, which is a cofactor of SAHH [21]. In order to determine if SAHH is a direct or an indirect target of Dyrk1a, we analyzed the activity of NQO1 in liver of transgenic mice. We found an increased activity of NQO1 not only in Tg152F7 (Cbs+/+ Tg 152F7; Fig. 3D), Tg 189N3 but also in Ts65Dn mice compared to non-transgenic mice (Fig. 3D and Table 3). Moreover, Cbs+/- mice crossbred with Tg 152F7 mice (Cbs+/- Tg 152F7; Fig. 3D) counteracted the decreased NQO1 activity when compared with Cbs+/- mice (Cbs+/- Tg -; Fig. 3D). Commensurate with the increased activity, mRNA expression of NQO1 was 1.8 fold higher in liver of Tg 189N3 and Ts65Dn mice compared to non-transgenic mice (Table 3).
###end p 36
###begin title 37
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Relative expression of NQO1 gene based upon Q-PCR data and NQO1 activity obtained from non-transgenic and Tg189N3 and Ts65Dn mice.
###end title 37
###begin p 38
###xml 180 181 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 210 211 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 218 224 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 218 224 216 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8224;</sup></bold>
###xml 224 225 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
The values of Tg189N3 and Ts65Dn were normalized to the mean Tg - mice from each line. Data correspond to means +/- SEM and the statistical analysis was done by Student's unpaired t-tests. n = number of mice. *p<0.03; daggerp<0.01.
###end p 38
###begin title 39
Harmine inhibits the effects of DYRK1A over-expression on SAHH activity
###end title 39
###begin p 40
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Bain1">[22]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Kuhn1">[23]</xref>
###xml 239 246 239 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6A</xref>
###xml 339 346 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6A</xref>
###xml 403 410 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6A</xref>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6A</xref>
###xml 716 723 716 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6B</xref>
###xml 785 792 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6B</xref>
###xml 873 880 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6B</xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 187 202 <span type="species:ncbi:10090">transgenic mice</span>
###xml 308 323 <span type="species:ncbi:10090">transgenic mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 461 476 <span type="species:ncbi:10090">transgenic mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 685 700 <span type="species:ncbi:10090">transgenic mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
In order to determine if the effects are dependent on Dyrk1a kinase activity, we treated Tg 189N3 mice with harmine, the most potent and specific inhibitor of Dyrk1a [22], [23]. Even non-transgenic mice treated with harmine (Tg - Harmine, Fig. 6A) showed an increased SAHH activity compared to untreated non-transgenic mice (Tg - Vehicle, Fig. 6A), Tg 189N3 mice treated with harmine (Tg 189N3 Harmine, Fig. 6A) had the same increased activity than that of non-transgenic mice treated with harmine (Tg - Harmine, Fig. 6A), which shows that treatment with harmine prevents the increase of SAHH activity in Tg 189N3 mice. Moreover, even if harmine treatment has no effect on NQO1 in non transgenic mice (Tg - Harmine, Fig. 6B), treatment with harmine in Tg 189N3 mice (Tg 189N3 Harmine, Fig. 6B) reduced NQO1 activity compared to non treated Tg 189N3 mice (Tg 189N3 Vehicle, Fig. 6B).
###end p 40
###begin title 41
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Effects of harmine on hepatic SAHH and NQO1 activities, and on plasma Hcy levels in Tg 189N3 mice.
###end title 41
###begin p 42
###xml 271 272 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
Hepatic SAHH (A) and NQO1 (B) activities are presented as percent of untreated (Vehicle) non-transgenic (Tg -) mice activities. (C) Plasma Hcy level. Data correspond to means +/- SEM and the statistical analysis was done with one-way ANOVA followed by Student's unpaired t-test. n = number of mice.
###end p 42
###begin p 43
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6C</xref>
###xml 325 332 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g006">Fig. 6C</xref>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
To confirm the implication of Dyrk1a on Hcy level, we also assayed plasma Hcy levels in harmine-treated non-transgenic and Tg 189N3 mice. There was a trend towards a 1.4 fold increase of plasma Hcy concentration in harmine treated Tg 189N3 (Tg 189N3 Harmine, Fig. 6C) compared to non-treated Tg 189N3 mice (Tg 189N3 Vehicle, Fig. 6C) although this was not statistically significant.
###end p 43
###begin title 44
SAHH and NQO1 activities were increased in lymphoblastoid cell lines
###end title 44
###begin p 45
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t004">Table 4</xref>
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t004">Table 4</xref>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAHH</italic>
###xml 535 542 535 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t004">Table 4</xref>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t004">Table 4</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 76 82 <span type="species:ncbi:9606">humans</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 605 613 <span type="species:ncbi:9606">patients</span>
In order to determine whether the activities observed in mice does apply to humans, we also analyzed the SAHH and NQO1 activity in lymphoblastoid cell lines (LCLs) from patients with DS. We first confirmed that LCLs from patients with DS (T21, Table 4) overexpressed 1.5 fold DYRK1A at the mRNA and protein level compared to LCLs from control individuals (control, Table 4). We not only found an increased SAHH activity but also a decreased mRNA SAHH expression in LCLs from patients with DS compared to LCLs from control individuals (Table 4). Moreover, the NQO1 activity was also increased in LCLs from patients with DS, concomitant with an increased mRNA expression (Table 4).
###end p 45
###begin title 46
Relative expression of DYRK1A, SAHH and NQO1 and SAHH and NQO1 activities obtained from lymphoblastoid cell lines.
###end title 46
###begin p 47
###xml 258 259 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 289 290 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 297 303 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 297 303 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8224;</sup></bold>
###xml 303 304 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
The values of lymphoblastoid cell lines (LCLs) from patients with DS (T21) were normalized to the mean lymphoblastoid cell lines from control individuals (control). Data correspond to means +/- SEM and the statistical analysis was done by Student's unpaired t-tests. n = number of LCLs. * p<0.05; daggerp<0.006.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 227 230 227 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Welch1">[2]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Draheim2">[24]</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hamelet1">[10]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hamelet1">[10]</xref>
###xml 1233 1241 1233 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007540-g005">Figure 5</xref>
###xml 869 875 <span type="species:ncbi:10090">murine</span>
###xml 901 906 <span type="species:ncbi:9606">human</span>
###xml 914 920 <span type="species:ncbi:10090">murine</span>
Elevated plasma Hcy level is well recognized as an important vascular risk factor and atherosclerosis in the coronary, cerebrovascular and peripheral arterial circulation, even if the degree of hyperhomocysteinemia is moderate [2]. On the contrary, adults with Down syndrome seem to be protected against atherosclerosis, despite having elevated risk factors, such as elevated total body fat, higher levels of triglycerides and C-reactive protein, and lower levels of moderate to vigorous physical activity [24]. As we found a negative correlation between plasma Hcy levels and hepatic DYRK1A expression which underlines the effect of hyperhomocysteinemia on DYRK1A expression [10], we decided to analyze the over-expression of DYRK1A on Hcy metabolism. Here we show that overexpression of DYRK1A diminishes the plasma Hcy level. This result was obtained with different murine models which contain the human or the murine gene, with duplications of increasing complexity and over-expression of Dyrk1a. Therefore, we see an effect of Hcy level on DYRK1A expression [10], but also an effect of DYRK1A expression on Hcy level, which is underlined by the correlation between plasma Hcy level and hepatic DYRK1A protein expression (10 and Figure 5).
###end p 49
###begin p 50
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Licastro1">[6]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Pogribna1">[11]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Galletti1">[13]</xref>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 741 745 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Pogribna1">[11]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Pogribna1">[11]</xref>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 565 573 <span type="species:ncbi:9606">children</span>
###xml 628 636 <span type="species:ncbi:9606">children</span>
###xml 697 702 <span type="species:ncbi:9606">human</span>
###xml 721 726 <span type="species:ncbi:10090">mouse</span>
###xml 873 881 <span type="species:ncbi:9606">patients</span>
###xml 990 998 <span type="species:ncbi:9606">patients</span>
As increased expression of DYRK1A and low plasma Hcy levels have been associated with DS [6], [11]-[13], we also analyzed the contribution of DYRK1A on Hcy levels in a mouse trisomic complex, the Ts65Dn mice. We found an increased expression of DYRK1A in liver and a decreased level of plasma Hcy level in Ts65Dn. DYRK1A and CBS are two genes located on chromosome 21. Our results show that over-expression of DYRK1A has no effect on CBS activity, which is in agreement with the hepatic SAM levels (an allosteric activator of CBS). It has been demonstrated that DS children have increased cystathionine level relative to normal children, consistent with over-expression of the CBS gene present on human chromosome 21 and mouse chromosome 17 [11]. On the one hand, the over-expression of CBS in DS is the predominant mechanism to explain the decrased plasma Hcy level in DS patients [11]. On the other hand, the DYRK1A over-expression likely plays a role on decreased plasma Hcy level in DS patients however, to a lesser extent.
###end p 50
###begin p 51
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Bain1">[22]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Kuhn1">[23]</xref>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Pogribna1">[11]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Galletti1">[13]</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">children</span>
###xml 1197 1201 <span type="species:ncbi:10090">mice</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
###xml 1431 1435 <span type="species:ncbi:10090">mice</span>
We showed that over-expression of DYRK1A increases the SAHH activity not only in mice, but also in LCLs obtained from DS patients. Moreover, treatment with harmine, the most potent and specific inhibitor of Dyrk1a [22], [23], demonstrates that the increased SAHH activity depends on Dyrk1A kinase activity. We also established a correlation between plasma Hcy level, hepatic DYRK1A protein expression and hepatic SAHH activity. However, the increased hepatic SAHH activity was not associated with statistical difference in hepatic SAH levels. A previous study showed a lower concentration of plasma Hcy and SAH levels in DS children than in plasma of control subjects [11]. Galletti et al. also demonstrated that the intracellular concentration of SAH is significantly reduced in DS erythrocytes, paralleling the low plasma Hcy levels, and the intracellular SAM concentration is the same as in the control cells [13]. Therefore the diminution of SAH levels could be due to other genes located on chromosome 21. We found a decreased hepatic SAM levels, associated with a decrease of the SAM/SAH ratio in Ts65Dn, which suggests an altered SAM-dependent methylation, but not in Tg 152F7 and Tg 189N3 mice. Interestingly, Ts65Dn mice also contain three copies of DNMTa1 gene, which encodes for a DNA methyltransferase. The over-expression of this DNA methyltransferase could decrease SAM level and the SAM/SAH ratio in liver of Ts65Dn mice, which could influence the methylation index and then the gene expression.
###end p 51
###begin p 52
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Kloor1">[25]</xref>
###xml 1549 1553 1549 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Hershfield1">[21]</xref>
###xml 1641 1645 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Han1">[26]</xref>
###xml 1931 1935 1931 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Aleksunes1">[27]</xref>
###xml 2234 2238 2234 2238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Joung1">[28]</xref>
###xml 2403 2407 2403 2407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Siarey1">[29]</xref>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 926 934 <span type="species:ncbi:9606">patients</span>
###xml 1253 1257 <span type="species:ncbi:10090">mice</span>
###xml 1293 1301 <span type="species:ncbi:9606">patients</span>
###xml 2335 2339 <span type="species:ncbi:10090">mice</span>
###xml 2398 2402 <span type="species:ncbi:10090">mice</span>
SAHH cleaves SAH to adenosine and Hcy, but this reaction is easily reversible by the same enzyme [25]. Although the equilibrium dynamics of the SAHH reaction strongly favor SAH formation, under physiological conditions, the rapid metabolism of SAHH end products Hcy (via transsulfuration and remethylation pathways) and adenosine (via the adenosine deaminase or adenosine kinase) drive the SAHH reaction in the hydrolysis direction. The activation of the SAHH activity in the reverse direction would be expected to promote the diminution of Hcy. The finding that DYRK1A over-expression activated SAHH activity is novel and is also consistent with no limitation of the remethylation pathway. We found an increased expression of the three enzymes implicated in the remethylation pathway in liver of Tg189N3 mice. However, the SAHH expression was decreased not only in liver of Tg 189N3 and Ts65Dn mice, but also in LCLs from DS patients. Because SAHH transcripts were decreased, the finding of increased SAHH activity must represent a post-transcriptional modification of the enzyme. The activation of SAHH activity can be due to a direct or an indirect mechanism. We found an increased activity of NQO1 not only in liver of Tg 152F7, Tg 189N3 and Ts65Dn mice, but also in LCLs obtained from DS patients. Moreover, treatment with harmine demonstrates that the increased NQO1 activity depends on Dyrk1A kinase activity. The increased activity of NQO1 is followed by an increase of a by-product of the enzyme reaction, NAD+, which is a cofactor of SAHH [21]. NQO1 is an inducible enzyme, and its overexpression protects cells against cell death [26]. The cell's major strategy of coping with oxidative stress is to increase the anti-oxidative potential by upregulating defense enzymes through activation of the nuclear factor-E2-related factor-2 (Nrf2). Nrf2 can activate many phase II detoxifying and antioxidant genes including NQO1 [27]. Nrf2 dissociates from the cytoskeletal binding protein KEAP1 and translocates to the nucleus in response to oxidative stress. It has been demonstrated that the PI3K/Akt pathways facilitate the release of NRF2 from KEAP1 and its subsequent translocation, and regulate ROS-dependent Nrf2 activation [28]. Previous results have shown that phosphorylation of protein kinase Akt was increased in Ts65Dn mice, and we found an increased hepatic NQO1 activity in these mice [29]. Then over-expression of DYRK1A could modulate the hepatic SAHH activity through an indirect mechanism initiated by its serine/threonine kinase activity.
###end p 52
###begin p 53
In conclusion, our results might give clues to understand the protective effect of DS against vascular defect through a decrease of Hcy level, and a link between metabolomics and signalling pathways.
###end p 53
###begin title 54
Methods
###end title 54
###begin title 55
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and genotyping
###end title 55
###begin p 56
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 360 363 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Watanabe1">[14]</xref>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 492 495 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 558 561 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 598 601 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 601 604 601 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Watanabe1">[14]</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Smith2">[30]</xref>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Smith2">[30]</xref>
###xml 1130 1133 1130 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 1133 1136 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1721 1724 1721 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">App</italic>
###xml 1728 1731 1728 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 1781 1785 1781 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Reeves1">[31]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">Mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 772 777 <span type="species:ncbi:9606">human</span>
###xml 778 783 <span type="species:ncbi:4932">yeast</span>
###xml 1110 1115 <span type="species:ncbi:9606">human</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
###xml 1276 1282 <span type="species:ncbi:10090">murine</span>
###xml 1579 1583 <span type="species:ncbi:10090">mice</span>
###xml 1655 1659 <span type="species:ncbi:10090">mice</span>
###xml 1696 1701 <span type="species:ncbi:10090">mouse</span>
###xml 1799 1803 <span type="species:ncbi:10090">mice</span>
Mice were maintained in a controlled environment with unlimited access to food and water on 12 h light/dark cycle. All procedures were carried out in accordance with internal guidelines of the French Agriculture Ministry for animal handing. Number of mice and suffering were minimized as possible. Mice heterozygous for targeted disruption of the Cbs gene (Cbs+/-) were generously donated by Dr. N. Maeda (Department of Pathology, University of North Carolina, Chaped Hill, NC, USA) [14]. Cbs+/- mice, on a C57BL/6 background were obtained by mating male Cbs+/- mice with female wild-type C57BL/6 (Cbs+/+) mice. DNA isolated from 4 week-aged mice tail biopsies was subjected to genotyping of the targeted CBS allele using a polymerase chain reaction (PCR) assay [14]. The human yeast artificial chromosome 152 F7 (YAC-152F7) strain has been previously described [30]. This transgenic line (Tg 152F7) contains the genes PIGP, TTC3, DSCR9, DSCR3 and DYRK1A. The YAC-152F7 line, which was constructed in an FVB/N background, was backcrossed on a C57BL/6 background. Genotyping was performed by PCR using specific human primers [30]. Cbs+/- and Tg 152F7 mice, on the same background, were crossbred. Male from each genotype from the same litter, two months of age, were used. The murine bacterial artificial chromosome 189 N3 (BAC-189N3) strain has been constructed by electroporating HM-1 embryonic stem (ES) cells with the retrofitted BAC-189N3. ES clone was selected for overexpression of Dyrk1a, and injected into blastocysts (J Delabar, personal communication). Female Tg 189N3 mice and control from the same litter, two months of age, were used. Ts65Dn mice possess a third copy of a region of mouse chromosome 16 from App to Mx1, orthologous to the DS critical region of HSA 21 [31]. Male Ts65Dn mice and control, from the same litter, six months of age, were used.
###end p 56
###begin title 57
Harmine treatment
###end title 57
###begin p 58
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
Mice were injected intraperitoneally overnight, with 10 mg/kg of harmine hydrochloride hydrate (Fisher Scientific, Illkirch, France) dissolved in 0.9% NaCl. The next morning, mice were injected once more for 1 hour. Control mice were injected with 0.9% NaCl.
###end p 58
###begin title 59
Preparation of serum samples, tissue collection, and plasma total Hcy assay
###end title 59
###begin p 60
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 417 421 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Fortin1">[32]</xref>
###xml 571 575 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Ducros1">[33]</xref>
At the time of sacrifice, blood samples were collected into tubes containing a 1/10 volume of 3.8% sodium citrate, placed on ice immediately. Plasma was isolated by centrifugation at 2500 g for 15 min at 4degreesC. Liver was harvested, snap-frozen and stored at -80degreesC until use. Plasma total Hcy was assayed by using the fluorimetric high-performance liquid chromatography method described by Fortin and Genest [32]. The inter- and intra-assay coefficients of variation for mean tHcy level were 4.2% and 6.3% respectively and the linearity was from 1 to 100 microM [33].
###end p 60
###begin title 61
Cell Lines and Culture Conditions
###end title 61
###begin p 62
###xml 842 843 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 270 282 <span type="species:ncbi:9606">participants</span>
###xml 528 546 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 668 674 <span type="species:ncbi:9913">bovine</span>
Epstein-Barr virus-transformed lymphoblastoid cell lines (LCLs) are derived from healthy individuals and unrelated DS patients, recruited from the Institut Jerome Lejeune (Paris, France) and the CHU Saint-Etienne (France). Written informed consent was obtained from the participants or from their families, and the French biomedical ethics committee gave its approval for this study (Comite de Protection des Personnes dans la Recherche Biomedicale number 2003-036 and 2005-06). DS was confirmed by karyotyping before and after Epstein-Barr virus transformation. Culture media consisted of Opti-MEM with GlutaMax (Invitrogen, Cergy, France) supplemented with 5% fetal bovine serum from a unique batch and 1% penicillin and streptomycin mix (10,000 U/mL). Cell lines were grown at 37degreesC in humidified incubators, in an atmosphere of 5% CO2. Cells were harvested by centrifugation, washed in 5 mL PBS, followed by another centrifugation, and stored at -80degreesC.
###end p 62
###begin title 63
Determination of hepatic SAM and SAH concentrations
###end title 63
###begin p 64
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Gellekink1">[34]</xref>
###xml 579 581 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 582 583 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 593 594 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 674 675 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 706 708 706 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 709 710 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 784 785 784 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 816 818 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 819 820 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
Levels of SAM and SAH in liver tissues were determined by stable isotope dilution liquid chromatography tandem mass spectrometry in an adapted method from Gellekink et al. [34]. In brief, frozen tissues were homogenized with ice-cold perchloric acid then centrifugated. Supernatant cleanup was performed with solid phase extraction (SPE) columns after neutralization of the acidified samples. The type of SPE cartridges used is phenyl boronic acid (SPE Bond Elut - PBA, 100 mg) from Varian (Courtaboeuf, les Ulis, France). Two isotopically labeled internal standards were used : 13C5-SAH and D3-SAM. Analytes were detected using the transitions m/z 399-250 (SAM), 402-250 (D3-SAM), 385-136 (SAH), 390-136 (13C5-SAH) for quantification and the transitions m/z 399-136 (SAM), 402-136 (D3-SAM), 385-134 (SAH), 390-134 (13C5-SAH) for qualification. The detection limits (signal-to-noise ratio = 3), estimated from the lower calibration point, were 0.4 nmol/L for SAM and 0.6 nmol/L for SAH. The variability of the assay expressed as CVs (n = 4) were 13.3% for SAM and 9.6% for SAH with a plasma pool containing 130 nmol/L of SAM and 11 nmol/L of SAH.
###end p 64
###begin title 65
Western blot analysis
###end title 65
###begin p 66
###xml 421 432 <span type="species:ncbi:3704">Horseradish</span>
Proteins preparations were subjected to SDS electrophoresis on 7.5% acrylamide gels under reducing conditions and transferred to Hybond-C Extra membrane (GE Healthcare Europe GmbH, Saclay, France). After transfer, membranes were blocked in 10% nonfat dry milk in Tris-saline buffer (1.5 mM Tris, 5 mM NaCl, 0.1% Tween 20) and probed overnight at 4degreesC with DYRK1A antibody (1/500) (Abnova corporation, Tebu, France). Horseradish peroxidase-conjugated secondary antibody and Western Blotting Luminol Reagent (Santa Cruz Biotechnology, Tebu, France) were used to detect specific proteins. beta-actin (1/4000) (Sigma-Aldrich, France) was used as an internal control. Digitized images of the immunoblots obtained using a LAS-3000 imaging system (Fuji Photo Film Co., Ltd.) were used for densitometric measurements with an image analyzer (UnScan It software, Silk Scientific Inc.).
###end p 66
###begin title 67
Enzyme Activity assays
###end title 67
###begin p 68
###xml 147 151 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Miller1">[35]</xref>
###xml 650 654 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Villanueva1">[36]</xref>
###xml 832 836 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Ernster1">[37]</xref>
###xml 864 868 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Benson1">[38]</xref>
Determination of CBS activity was assayed on 400 microg of total proteins obtained from liver samples, determined by Bradford method, as described [35]. Proteins were incubated for 1h at 37degreesC with 1 mM of propargylglycine, 0.2 mM of pyridoxal phosphate, 10 mM of L-serine, 10 mM of DL-Hcy, 0.4 mM of SAM, using DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) based-assay. All the chemical products were obtained from Sigma (Sigma-Aldrich, France). Determination of SAH hydrolase activity was assayed on 300 microg of total proteins obtained from liver samples or lymphoblastoid cell lines following the protocol described by Villanueva and Halsted [36]. Determination of NQO1 activity was assayed on 150 microg of total proteins obtained from liver samples or lymphoblastoid cell lines following the protocol described by Ernster [37], modified by Benson et al. [38].
###end p 68
###begin title 69
RNA extraction and determination of mRNA levels
###end title 69
###begin p 70
###xml 519 520 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 986 993 968 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007540-t005">table 5</xref>
###xml 1726 1730 1680 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007540-Tichopad1">[39]</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
Total RNA was prepared from mice liver with the Nucleospin(R) RNA II kit (Macherey-Nagel, Hoerdt). The quantity and purity of the RNA was assessed by measuring absorbance at 260 and 280 nm. Reverse transcription was carried out on 2 microg total RNA as described by the manufacturer (Ambion, UK). The mRNA levels were assessed by quantitative RT-PCR (Q-PCR). cDNA (0.4 microL) was diluted with PCR mix (Light Cycler FastStart DNA Master SYBR Green I Kit, Roche Diagnostics) containing a final concentration of 3 mM MgCl2 and 0.5 microM of primers in a final volume of 10 microL. The primers were designed by Primer 3 software. The primers pairs were selected to yield a single amplicon based on dissociation curves. The peptidylprolyl isomerase B (PPIB) mRNA, the hypoxanthine phosphoribosyltransferase (HPRT) mRNA, the fasciculation and elongation zeta protein 1 (fez), and the Zinc finger protein (AB000468) mRNA were used as an endogenous control. Primer sequences were given in the table 5. Q-PCR was performed on total RNA isolated from liver of individual mice or from individual LCLs in a Lightcycler system (Roche Diagnostics). The thermal cycler parameters were as follows : hold for 8 min at 95degreesC for one cycle followed by amplification of cDNA for 40 cycles with melting for 5 s at 95degreesC, annealing for 5 s at 65degreesC and extension for 10 s at 72degreesC. Each reaction was performed in triplicate. Subsequent assay efficiency calculations were carried out in Light Cycler Relative Quantification Software (Roche Diagnostics). As the efficiency of the target gene and the control genes were comparable, DeltaCp analysis of the results allows to assess the ratio of the target mRNA versus control mRNA [39].
###end p 70
###begin title 71
Primer sequences for real-time quantitative reverse transcription-polymerase chain reaction (Q-PCR) (all primers are listed 5' to 3').
###end title 71
###begin title 72
Data analysis
###end title 72
###begin p 73
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 608 609 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 618 619 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analysis was done with one-way ANOVA followed by Student's unpaired t-test using Statview software. In both cases, Student-Newman-Keuls tests were used for multiple pairwise comparaisons. The results are expressed as mean +/- SEM. Correlations between Hcy level, DYRK1A protein expression and SAHH activity were determined by using Spearman's rank correlation as data were not normally distributed according to Shapiro - Wilk test. The multivariate analysis was performed according to the principal component analysis (PCA). Data were analyzed using R software () and considered significant when p<0.05. A p value of 0.06-0.10 was considered to indicate a strong statistical tendency due to the small sample size.
###end p 73
###begin title 74

###end title 74
###begin p 75
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cbs</italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
We thank Dr N. Maeda (Department of Pathology, University of North Carolina, Chapel Hill, NC) for providing heterozygous Cbs mice. We thank C. Imbert, F. Lequellec, A. Ledru and A. Djemat for technical assistance.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
Homocysteine metabolism.
###end article-title 77
###begin article-title 78
Homocysteine and atherothrombosis.
###end article-title 78
###begin article-title 79
Down's syndrome: an atheroma-free model?
###end article-title 79
###begin article-title 80
###xml 54 61 <span type="species:ncbi:9606">persons</span>
Cardiovascular disease prevalence and risk factors of persons with mental retardation.
###end article-title 80
###begin article-title 81
Down's syndrome and atherosclerosis.
###end article-title 81
###begin article-title 82
Does Down's syndrome support the Homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21.
###end article-title 82
###begin article-title 83
Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity.
###end article-title 83
###begin article-title 84
###xml 83 88 <span type="species:ncbi:9606">human</span>
DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine.
###end article-title 84
###begin article-title 85
The protein kinase DYRK1A regulates caspase-9-mediated apotposis during retina development.
###end article-title 85
###begin article-title 86
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Effect of hyperhomocysteinemia on the protein DYRK1A in liver of mice.
###end article-title 86
###begin article-title 87
###xml 27 35 <span type="species:ncbi:9606">children</span>
Homocysteine metabolism in children with Down syndrome: in vitro modulation.
###end article-title 87
###begin article-title 88
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
###end article-title 88
###begin article-title 89
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome.
###end article-title 89
###begin article-title 90
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.
###end article-title 90
###begin article-title 91
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome.
###end article-title 91
###begin article-title 92
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Segmental trisomy as a mouse model for Down syndrome.
###end article-title 92
###begin article-title 93
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Segmental trisomy as a mouse model for Down syndrome.
###end article-title 93
###begin article-title 94
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.
###end article-title 94
###begin article-title 95
The metabolism of homocysteine: pathways and regulation.
###end article-title 95
###begin article-title 96
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Characterization of homocysteine metabolism in the rat liver.
###end article-title 96
###begin article-title 97
###xml 38 43 <span type="species:ncbi:9606">human</span>
S-Adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterization.
###end article-title 97
###begin article-title 98
The selectivity of protein kinase inhibitors: a further update.
###end article-title 98
###begin article-title 99
DYRK1A Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy.
###end article-title 99
###begin article-title 100
Prevalence of physical inactivity and recommended physical activity in community-based adults with mental retardation.
###end article-title 100
###begin article-title 101
###xml 107 113 <span type="species:ncbi:9913">bovine</span>
Effects of ions on adenosine binding and enzyme activity of purified S-adenosylhomocysteine hydrolase from bovine kidney.
###end article-title 101
###begin article-title 102
Protective effect of sulforaphane against dopaminergic cell death.
###end article-title 102
###begin article-title 103
Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.
###end article-title 103
###begin article-title 104
Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target.
###end article-title 104
###begin article-title 105
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
###end article-title 105
###begin article-title 106
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from human chromosome 21q22.2.
###end article-title 106
###begin article-title 107
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for Down syndrome exhibits learning and behaviour deficits.
###end article-title 107
###begin article-title 108
Measurement of homocyst(e)ine in the prediction of atherosclerosis.
###end article-title 108
###begin article-title 109
Methods for homocysteine analysis and biological relevance of the results.
###end article-title 109
###begin article-title 110
Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma.
###end article-title 110
###begin article-title 111
###xml 46 50 <span type="species:ncbi:10116">rats</span>
Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism.
###end article-title 111
###begin article-title 112
Hepatic transmethylation reactions in micropigs with alcoholic liver disease.
###end article-title 112
###begin article-title 113
Methods Enzymol
###end article-title 113
###begin article-title 114
Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity.
###end article-title 114
###begin article-title 115
Standardized determination of real-time PCR efficiency from a single reaction set-up.
###end article-title 115
###begin p 116
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 116
###begin p 117
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by an EU grant AnEUploidy and by the Fondation Jerome Lejeune. Christophe Noll and Faycal Guedj are supported by a fellowship from the Ministere de l'Enseignement superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 117

